EUVIMEDEUVIMED entdecken
Vergleichsstudie

Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients

Lihua Wang, Yueqi Cao, Weijie Yuan, Chuanming Hao, Li Yao, Cheng Xue, Pei Yu, Changlin Mei

American Journal of Nephrology · 2025

DOI: 10.1159/000546158 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Lihua Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Disease and Blood Purification Centre, 2nd Hospital of Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Renal Dialysis, Anemia, Glycine, Renal Insufficiency, Chronic. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Erythropoietin and roxadustat are commonly used to manage anemia in hemodialysis-dependent chronic kidney disease (CKD) patients, but the comparative safety and effectiveness are unknown.

Methods

This is a retrospective cohort study. Data were extracted from Tianjin Healthcare and Medical Big Data Platform. We screened all patients with CKD stage G5 and anemia (hemoglobin

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisAnemiaGlycineRenal Insufficiency, ChronicErythropoietinIsoquinolinesHematinicsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedPropensity ScoreCardiovascular DiseasesTreatment OutcomeThromboembolism

Stichwörter der Autor:innen

Cardiovascular eventsChronic kidney diseaseErythropoietinHemodialysisRenal anemia

Substanzen

GlycineErythropoietinroxadustatIsoquinolinesHematinics

Autor:innen und Institutionen

  • Department of Kidney Disease and Blood Purification Centre, 2nd Hospital of Tianjin Medical University, Tianjin, China.
  • Division of Nephrology, Department of Medicine, Shanghai First People Hospital, Jiao Tong University School of Medicine, Shanghai, China.
  • Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.
  • Division of Nephrology, Kidney Institute of PLA, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Division of Nephrology, Kidney Institute of PLA, Changzheng Hospital, Naval Medical University, Shanghai, China, chlmei1954@126.com.

Zitieren

APA

Wang, L., Cao, Y., Yuan, W., Hao, C., Yao, L., Xue, C., Yu, P., & Mei, C. (2025). Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients. American Journal of Nephrology. https://doi.org/10.1159/000546158

Vancouver

Wang L, Cao Y, Yuan W, Hao C, Yao L, Xue C, et al. Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients. American Journal of Nephrology. 2025. doi:10.1159/000546158

BibTeX
@article{Wang2025,
  author = {Wang, Lihua and Cao, Yueqi and Yuan, Weijie and Hao, Chuanming and Yao, Li and Xue, Cheng and Yu, Pei and Mei, Changlin},
  title = {Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000546158}
}
Kostenlos starten →